Ken Griffin's position in Fate Therapeutics is currently worth $19.6 Million. That's 0.02% of their equity portfolio (826th largest holding). The investor owns 2.65% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q4 2015. Since then Ken Griffin bought shares 34 more times and sold shares on 34 occasions. The investor's estimated purchase price is $51.5 Million, resulting in a loss of 62%.